Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Generic Sweden AB's Debt-to-EBITDA or its related term are showing as below:
OSTO:GENI's Debt-to-EBITDA is not ranked *
in the Software industry.
Industry Median: 0.98 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Generic Sweden AB Debt-to-EBITDA Related Terms
Generic Sweden AB Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Generic Sweden AB's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:GENI vs CRM, SHOP, UBER: Debt-to-EBITDA Comparison
For the Software - Application subindustry, Generic Sweden AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Generic Sweden AB Debt-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Generic Sweden AB's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Generic Sweden AB's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Generic Sweden AB (OSTO:GENI) has a Debt-to-EBITDA of 0.00 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Generic Sweden AB. According to the industry distribution chart, Generic Sweden AB ranks #999999 out of 1722 companies in the Software industry.
Is Generic Sweden AB's Debt-to-EBITDA too high?
Generic Sweden AB's current Debt-to-EBITDA is 0.00. Based on the distribution chart, Generic Sweden AB ranks #999999 out of 1722 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Generic Sweden AB has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Generic Sweden AB's Debt-to-EBITDA compare to CRM and SHOP?
According to the Software industry distribution chart, Generic Sweden AB ranks #999999 out of 1722 companies for Debt-to-EBITDA. This places Generic Sweden AB in the lower half of its industry. The industry median Debt-to-EBITDA is 0.98. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Software company?
The median Debt-to-EBITDA among Software companies is 0.98, based on 1,722 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Generic Sweden AB. For the Software industry, the median Debt-to-EBITDA is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Generic Sweden AB's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Generic Sweden AB (OSTO:GENI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr59.35, compared to a current price of kr39.40 — trading 33.6% below its estimated fair value. The current Debt-to-EBITDA is 0.00. Generic Sweden AB's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Generic Sweden AB (OSTO:GENI), the current Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Generic Sweden AB (OSTO:GENI) Overvalued in 2026?
Based on GuruFocus' analysis, Generic Sweden AB stock appears to be undervalued.
The current stock price of kr39.40 is trading 33.6% below its estimated GF Value™ of kr59.35.
GuruFocus considers Generic Sweden AB to be Significantly Undervalued.
Key valuation signals for OSTO:GENI:
Debt-to-EBITDA: 0.00
GF Value™: kr59.35 vs. price of kr39.40 (33.6% below fair value)
No single metric tells the full story. See the OSTO:GENI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Generic Sweden AB is a technology company providing high-tech messaging services for all applications. The company offers a platform for digital communication services that can be integrated into customers' internal or external communication flow. The services are provided through a Communication Platform as a Service (CPaaS) model. Generic's customers are found in all areas and with a special position in alarms and security, care and e-health as well as e-commerce and logistics.
89GF Score
Get the complete analysis for OSTO:GENI
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:GENI has been successfully added to your 
